| Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths AG Zauber, SJ Winawer, MJ O'Brien, I Lansdorp-Vogelaar, ... New England Journal of Medicine 366 (8), 687-696, 2012 | 3238 | 2012 |
| Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to … BK Edwards, E Ward, BA Kohler, C Eheman, AG Zauber, RN Anderson, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2010 | 2332 | 2010 |
| Evaluating test strategies for colorectal cancer screening: a decision analysis for the US Preventive Services Task Force AG Zauber, I Lansdorp-Vogelaar, AB Knudsen, J Wilschut, ... Annals of internal medicine 149 (9), 659-669, 2008 | 664 | 2008 |
| European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication European Colorectal Cancer Screening Guidelines Working Group Endoscopy 45 (01), 51-59, 2013 | 575 | 2013 |
| Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years FER Vuik, SAV Nieuwenburg, M Bardou, I Lansdorp-Vogelaar, ... Gut 68 (10), 1820-1826, 2019 | 547 | 2019 |
| Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force AB Knudsen, AG Zauber, CM Rutter, SK Naber, VP Doria-Rose, ... Jama 315 (23), 2595-2609, 2016 | 471 | 2016 |
| Cost-effectiveness of colorectal cancer screening I Lansdorp-Vogelaar, AB Knudsen, H Brenner Epidemiologic reviews 33 (1), 88-100, 2011 | 341 | 2011 |
| Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial M Bretthauer, MF Kaminski, M Løberg, AG Zauber, J Regula, EJ Kuipers, ... JAMA internal medicine 176 (7), 894-902, 2016 | 280 | 2016 |
| European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk J Schüz, C Espina, P Villain, R Herrero, ME Leon, S Minozzi, I Romieu, ... Cancer epidemiology 39, S1-S10, 2015 | 262 | 2015 |
| Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening I Lansdorp-Vogelaar, M Van Ballegooijen, AG Zauber, JDF Habbema, ... JNCI: Journal of the National Cancer Institute 101 (20), 1412-1422, 2009 | 239 | 2009 |
| Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018 RGS Meester, CA Doubeni, AG Zauber, SL Goede, TR Levin, DA Corley, ... Cancer 121 (13), 2281-2285, 2015 | 214 | 2015 |
| Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know J Tinmouth, I Lansdorp-Vogelaar, JE Allison Gut 64 (8), 1327-1337, 2015 | 208 | 2015 |
| Contribution of screening and survival differences to racial disparities in colorectal cancer rates I Lansdorp-Vogelaar, KM Kuntz, AB Knudsen, M Van Ballegooijen, ... Cancer Epidemiology, Biomarkers & Prevention 21 (5), 728-736, 2012 | 195 | 2012 |
| The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: microsimulation analysis I to inform the American Cancer Society … EFP Peterse, RGS Meester, RL Siegel, JC Chen, A Dwyer, DJ Ahnen, ... Cancer 124 (14), 2964-2973, 2018 | 193 | 2018 |
| Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels E Toes-Zoutendijk, ME van Leerdam, E Dekker, F Van Hees, C Penning, ... Gastroenterology 152 (4), 767-775. e2, 2017 | 185 | 2017 |
| Family history and the natural history of colorectal cancer: systematic review NB Henrikson, EM Webber, KA Goddard, A Scrol, M Piper, MS Williams, ... Genetics in medicine 17 (9), 702-712, 2015 | 167 | 2015 |
| Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies H Cho, CN Klabunde, KR Yabroff, Z Wang, A Meekins, ... Annals of internal medicine 159 (10), 667-676, 2013 | 156 | 2013 |
| Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefits I Lansdorp-Vogelaar, R Gulati, AB Mariotto, CB Schechter, ... Annals of internal medicine 161 (2), 104-112, 2014 | 154 | 2014 |
| A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression KM Kuntz, I Lansdorp-Vogelaar, CM Rutter, AB Knudsen, ... Medical Decision Making 31 (4), 530-539, 2011 | 148 | 2011 |
| Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis AB De González, KP Kim, AB Knudsen, I Lansdorp-Vogelaar, CM Rutter, ... AJR. American journal of roentgenology 196 (4), 816, 2011 | 148 | 2011 |
